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TNF-a increases human melanoma cell invasion and migration in
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Inflammatory mediators have been reported to promote malignant cell growth, invasion and metastatic potential. More specifically,
we have recently reported that tumour necrosis factor alpha (TNF-a) increases melanoma cell attachment to extracellular matrix
(ECM) substrates and invasion through fibronectin. In this study, we extend these investigations asking specifically whether the TNF-a
effect on cell invasion and migration involves activation of proteolytic enzymes. We examined the effect of TNF-a on melanoma
expression/activation of type IV gelatinases matrix metalloproteinases 2 and 9 (MMPs -2 and -9) and general proteolytic enzymes.
Stimulation with TNF-a significantly increased both melanoma cell migration at 24 h (þ 21%) and invasion through fibronectin
(þ 35%) but did not upregulate/activate the expression of latent MMP-2 constitutively produced by these cells and did not
upregulate their general protease activity. However, the increased cell migration and invasion through fibronectin observed following
stimulation with TNF-a were inhibited by the general protease inhibitor a2 macroglobulin. These findings suggest that the
promigratory and proinvasive effect of TNF-a on this melanoma cell line may be mediated to some extent by induction of localised
cell membrane-bound degradative enzyme activity, which is not readily detected in biochemical assays.
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Proteolytic degradation of the basement membrane and the
extracellular matrix (ECM) and movement through it are regarded
as essential steps in the cascade of events leading to successful
tumour cell invasion and metastasis. Studies on human melanoma
have provided evidence that the plasminogen activator system and
the matrix metalloproteinase (MMP) enzyme systems play an
important role (Hofmann et al, 2000; Bodey et al, 2001); in
particular, expression of MMP-2, an enzyme that degrades collagen
IV in basement membranes, has been reported to increase in
relation to malignancy of human melanocytic lesions (Va¨isa¨nen
et al, 1996).
Another important element of successful tumour progression is
the generation of tumour stroma through induction of host’s
wound healing responses (Dvorak, 1986). Tumour stroma forma-
tion requires extensive tissue remodelling and is commonly
characterised by an inflammatory cellular infiltrate consisting of
macrophages, dendritic cells and lymphocytes (as reviewed by
Balkwill and Mantovani, 2001).
This close resemblance of tissue remodelling during wound
repair to tumour invasion and the fact that extensive host
connective tissue ‘desmoplastic reactions’ are observed in invasive
carcinomas but not around carcinomas in situ or benign tumours
has led to the suggestion that the tumour infiltrating inflammatory
cells and the cytokines they release may facilitate tumour cell
growth, invasion and metastasis (Balkwill and Mantovani, 2001).
One of the inflammatory cytokines that has been associated with
malignant tumour progression is TNF-a. A product of macro-
phages, TNF-a is one of the major mediators of inflammation that
orchestrates a series of immune and stromal cell responses
necessary for the destruction of damaged cells but also for the
repair of tissues during wound healing (Beutler, 1999). Its
production has been demonstrated in a number of human
epithelial and haematological malignancies and it appears that
both the protein itself and its receptor can be expressed in both the
malignant and/or the stromal cells (Balkwill, 2002), suggesting
potential autocrine and paracrine actions.
Studies on the effects of TNF-a using experimental models of
invasion and metastasis have shown that it can often act as a
tumour-promoting factor (reviewed by Balkwill, 2002). More
specifically for melanoma, TNF-a has been reported to upregulate
the expression of integrin subunits and the interaction of human
melanoma cells with ECM substrates (Dekker et al, 1994; Zhu et al,
2002). In addition, the more recent study from this laboratory
showed that TNF-a stimulated and alpha-melanocyte stimulating
hormone (a-MSH) opposed cell attachment to ECM substrates and
cell invasion through fibronectin, both of which would be
consistent with TNF-a promoting metastasis and a-MSH providing
partial protection against the action of TNF-a.
In the current study, we extend our investigations into the role
of inflammation in melanoma invasion by studying the effects of
TNF-a on melanoma cell migration and degradative enzyme
activity.Received 5 June 2003; revised 14 July 2003; accepted 15 July 2003
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Specifically, we examined the effect of TNF-a on melanoma cell
general proteolytic enzyme expression and expression/activation
of MMPs -2 and -9 and studied the extent to which degradative
enzymes are involved in the TNF-a induced cell responses by
looking at the effect of the general protease inhibitor a2
macroglobulin on TNF-a stimulated cell migration and invasion.
MATERIALS AND METHODS
Materials
Culture medium, additives and antibiotics were obtained from
Gibco BRL (Life Technologies, Paisley, UK) and Sigma Chemicals
Ltd. (Poole, UK). Foetal calf serum (FCS) was purchased from
GlobePharm Limited (Esher, UK); newborn calf serum (NBCS)
from Sigma Chemicals Ltd. (Poole, UK); trypsin/ethylenediamine-
tetraacetic acid (EDTA) and phosphate-buffered saline (PBS)
tablets from Oxoid Ltd. (Basingstoke, UK). Human fibronectin was
purchased from Sigma Chemicals Ltd. (Poole, UK); human
recombinant TNF-a and a2 macroglobulin from Roche Diagnostics
(Germany); and fluorescent BODIPYs casein (EnzCheks Protease
Assay Kit-green fluorescence) from Molecular Probes Inc. (Eugene,
USA). Tissue culture plastics were purchased from Corning Costar
Corporation (Cambridge, USA). All other chemicals were of
analytical grade.
Culture of cutaneous melanoma cells
The human cutaneous melanoma cell line HBL was established in
Professor Ghanem’s laboratory from a lymph node metastasis of a
nodular malignant melanoma (Ghanem et al, 1988). Cells were
cultured in Ham’s F10 (Gibco) medium supplemented with 5%
FCS, 5% NBCS, 2 103 mol l1 glutamine, 100 IU ml1 penicillin
and 100mg ml1 streptomycin sulphate.
For the experiments where a 24-h preincubation was required,
the cell culture medium was changed to RPMI-1640 medium
(Gibco) supplemented with 20 ng ml1 epidermal growth factor
(EGF), 0.2% (w/v) D-glucose solution, 0.1% (w/v) bovine serum
albumin (BSA), 2 103 mol l1 glutamine, 100 IU ml1 penicillin,
100mg ml1 streptomycin sulphate and the relevant concentration
of TNF-a was added. This serum-free medium was used for the
fibronectin invasion assays as described later (serum-free invasion
assay medium – SFIAM) and subsequently in all the assays where a
24-h preincubation period was required in order to keep the
experimental culture conditions the same.
Fibronectin invasion assay
A modification of the method we first described in Dewhurst et al
(1997) was used to study the effect of TNF-a and a2 macroglobulin
on the invasion of the melanoma cells through a layer of human
fibronectin. Briefly, a suspension of 1.8 105 HBL melanoma cells
(contained in 500 ml SFIAM with or without the appropriate drug
concentration as required) was added to Nunct tissue culture
inserts containing a polycarbonate filter with 8 mm diameter pores
covered with fibronectin (100 mg ml1). Cells were incubated for
20 h under standard culture conditions. At the end of the
incubation period, the cells that had invaded through the filter
(cells attached to the bottom of the well and to the undersurface of
the filter) were collected separately from the cells that had not
invaded (cells remaining attached to the upper surface of the
filter). A combined analysis of the cell counts was used to calculate
the percentage of the total population of cells that had invaded
through the fibronectin monolayer.
When a preincubation period was required prior to the invasion
assay, the cells were cultured in SFIAM with or without TNF-a
200 U ml1 for the last 24 h before passaging and adding to the
Nunct tissue culture inserts.
a2 macroglobulin was used as a general protease inhibitor after
initially confirming its activity against trypsin prior to using it to
inhibit proteolytic activity in the cell culture medium during the
fibronectin invasion assay.
Cell extraction of MMPs
Cell extraction of MMPs was performed when cell cultures were
70–80% confluent. Control and TNF-a-stimulated cells (incubated
with TNF-a 200 U ml1 for 24 h) were detached from the tissue
culture flask and were lysed using cell extraction buffer (contain-
ing 50 mM Tris-HCl pH¼ 7.4, 10 mM CaCl2, 0.05% Brij 35 and
0.25% Triton-X) for 15 min at 41C. The cell conditioned medium
was also collected for gelatin zymography analysis (following
centrifugation at 2000 g for 5 min to remove any cellular debris).
Cell extraction and measurement of general proteolytic
activity using BODIPYs casein
For the purpose of extraction of general proteolytic activity, the
melanoma cells were cultured in a 24-well plate at a density of
50 103 cells per well with or without TNF-a (at serial dilutions
ranging from 100 to 1000 U ml1) for 24 h. At the end of the
preincubation period, the conditioned medium was collected for
measurement of proteolytic activity, and extraction from the cells
was performed according to the protocol described above for
extraction of MMPs.
General proteolytic activity was measured in cell conditioned
medium and cell extracts using a quenched fluorescent BODIPYs
casein assay (Molecular Probes Inc.). BODIPYs FL casein is a
conjugate consisting of casein labelled with the fluorophore 4,4-
difluoro-5,7-dimethyl-4-bora-3a, 4a-diaza-s-indacene-3-propionic
acid (BODIPYs FL) (Jones et al, 1997). The casein is heavily
labelled with the fluorescent BODIPYs FL dye, resulting in almost
total quenching of the conjugate’s fluorescence. The assay detects
protease activity of a wide range of enzymes including serine
proteases, sulphydryl proteases, acid proteases and metalloprotei-
nases (Jones et al, 1997). The culture medium, or cell extracts, was
added to an equal volume of BODIPYs casein at a concentration
of 50 mg ml1 in a 10 mM Tris-HCl pH 7.8 assay buffer under low
light conditions. Duplicate samples were added to round-bottomed
96-well plates and were incubated for 24 h at 371C protected from
light. The fluorescence emitted by the cleavage products of the
quenched fluorescent substrate was proportional to the general
proteolytic activity of the sample and was measured using a Denley
Fluoscan platereader with an excitation filter at 480 nm and an
emission filter at 530 nm. The results are expressed as arbitrary
units of fluorescence following subtraction of background
fluorescence in the appropriate control.
As an internal control for the assay, trypsin at a concentration of
3.3mg ml1 was used in each experiment to demonstrate proteo-
lytic degradation of BODIPYs casein. The above concentration
was selected after initial experiments to confirm that the
fluorescence emitted by the cleaved substrate was proportional
to the concentration of trypsin. The following controls were also
included in each assay: BODIPYs casein alone, fresh culture
medium (SFIAM) with BODIPYs casein and extraction buffer with
BODIPYs casein. Cell extracts were diluted 1 : 20 in assay buffer
before being added to the fluorescent substrate as experimentation
showed this to be the optimum dilution to minimise the effect of
the extraction buffer itself on the fluorescent BODIPYs substrate.
Sodium dodecyl sulphate –polyacrylamide gel
electrophoresis gelatin zymography
Zymography was carried out on control (nontreated) and TNF-a
treated cell extracts (24-h cell preincubation in SFIAM containing
TNF-a 200 U ml1 as described above) and conditioned medium
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(collected at the end of the 24-h preincubation period). Proteins
were separated in nonreducing, nondenaturing conditions using a
10% resolving polyacrylamide gel containing 0.5% gelatin
substrate. Internal human purified MMP-2 and MMP-9 standards
(Biogenesis Ltd., Poole, UK) were included at concentrations of
20 ng per lane. After electrophoresis, the zymographs were
developed, fixed and stained according to the protocol described
by Baugh et al (1999).
Migration assay
A modified ‘scratch wound’ migration assay was used for the
assessment of the migration of the melanoma cells. The method
was previously described by Cha et al (1996) for the study of the
migration rate of keratinocytes.
Cells were plated in a 24-well culture plate in serum containing
Ham’s F10 culture medium at a density of 2 105 cells per ml per
well and were incubated for 24 h under standard culture
conditions. After 24 h, when the cells had attached to the bottom
of the tissue culture dish, the confluent cell monolayer was
scratched with a plastic pipette tip to create a cell free zone in the
well. The culture medium was removed and was replaced with an
equal volume of fresh SFIAM with or without TNF-a 200 U ml1 or
a2 macroglobulin. The cells were incubated for a further 24 h under
standard culture conditions. During this period, photographs of
the scratched cell monolayer were taken at predetermined time
points (0, 4, 8 and 24 h after the scratch was made) using an Apple
McIntosh video microscope (Open Lab 3.0.4 software) and
measurements of the distance between the two edges of the
scratch were recorded for each different time point. The
percentage reduction of the distance between the scratch edges
at the different time points represented the migration rate of the
melanoma cells. Triplicate wells were used for each experimental
condition.
Statistics
Control vs stimulated cell samples were analysed using Student’s
paired t-test for fibronectin invasion assays, migration assays and
for general protease activity assays.
RESULTS
Effect of TNF-a on HBL melanoma cell invasion through
fibronectin
Figure 1A illustrates the effect of TNF-a ranging from 100 to
500 U ml1 on HBL melanoma cell invasion through fibronectin
over 20 h. Unstimulated (control) cells showed a mean invasion
rate of 24.672.7% (n¼ 4 experiments). Stimulation with TNF-a
100 U ml1 significantly increased the invasion rate of the cells to
33.373.5% (Po0.05), which represents an increase of þ 35%
above the control level of invasion. Stimulation with higher
concentrations of TNF-a (250 and 500 U ml1) was less effective
and the increases in invasion did not reach statistical significance.
To determine the optimum period of exposure for maximum
response to TNF-a, cells were preincubated with TNF-a for 24 h
prior to the invasion assay and were also subsequently stimulated
with TNF-a again during the period of the invasion assay (a further
20 h). Preincubation with TNF-a resulted in a 43% increase in
invasion above control level (n¼ 3 experiments, Po0.05). Further
addition of TNF-a to the invasion assay did not increase any
further the invasiveness of these preincubated cells (results not
shown). On the basis of these data, we concluded that the
biological effects of TNF-a on invasion had occurred fully within
24 h.
Effect of TNF-a on HBL cell migration
A ‘scratch wound’ model was used to examine the effect of TNF-a
on melanoma cell migration. Cells stimulated with TNF-a
200 U ml1 (cytokine present during the 24-h assay) had a
significantly higher migration rate compared to the control
(nonexposed to TNF-a) cells. The migration rate (represented by
the percent reduction of the scratch width) of the TNF-a
stimulated cells was 53.274.4% by 24 h, whereas the migration
rate of the control cells at the same time point was 43.872.9%.
This represented a 21% increase in migration as a result of TNF-a
stimulation, Po0.05 based on eight experiments (as illustrated in
Figure 1B). There were no changes in the morphology of the
melanoma cells (control and TNF-a stimulated) at 8 or 24 h.
Effect of TNF-a on melanoma MMP-2 and MMP-9
production and activation
HBL cells were incubated with TNF-a 200 U ml1for 24 h prior to
cell extraction and collection of cell conditioned medium for
gelatin zymography (results are shown in Figure 2). Unstimulated
cells constitutively expressed MMP-2 in its latent form that was
shed into the conditioned medium. No MMP-2 activity was
recovered from the cell extracts.
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Figure 1 (A) Effect of TNF-a on HBL melanoma cell invasion through
fibronectin. A significant increase in invasion (þ 35% above control) was
observed with TNF-a at 100 U ml1. Control invasion is expressed as
100%. Results are the mean7s.e.m. of four experiments and triplicate wells
were used for each experimental condition in each experiment (*Po0.05).
(B) Time course of TNF-a action on HBL cell migration on plastic as
assessed by the ‘scratch wound’ migration assay. A significant increase in the
overall migration at 24 h was observed for the cells stimulated with TNF-a
at 200 U ml1. The data shown are mean values7s.e.m. from n¼ 8
experiments (*Po0.05).
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No MMP-9 activity was detected in the cell conditioned medium
or the cell extracts. Stimulation of cells with TNF-a did not result
in any upregulation or activation of the pro-MMP-2 in the
conditioned medium. Similarly, there was no evidence of TNF-a
upregulating MMP-9 production in the cell extracts or the cell
conditioned medium (again, as shown in Figure 2). Results shown
are of a single experiment representative of data obtained in three
different experiments.
Measurement of general protease activity and validation of
a2 macroglobulin activity
To confirm that the fluorescence emitted by cleavage of the
BODIPYs casein substrate was representative of proteolytic
enzyme activity, initial experiments used serial dilutions of trypsin
(see Figure 3A). From these, a concentration of trypsin was
selected and increasing concentrations of a2 macroglobulin were
added (see Figure 3B). The results show that significant inhibition
was achieved with 0.2 and 2 U ml1 a2 macroglobulin (Po0.05
based on n¼ 2 experiments). a2 macroglobulin at a concentration
of 2 U ml1 was used for future experiments as this achieved 84%
inhibition of trypsin activity.
Effect of TNF-a on general protease activity of the HBL
melanoma cells
Preincubation of cells with TNF-a at concentrations from 100 to
1000 U ml1 for 24 h prior to cell extraction and conditioned
medium collection, both of which were analysed, did not result in
any upregulation of protease activity as shown in Table 1. In
general, protease activity recovered from the cell extracts was
higher than that recovered from the conditioned medium possibly
due to a large amount of intracellular proteolytic enzymes,
including lysosomal stores of enzymes, being released during the
cell extraction. Both, though, were of a similar log order and
apparently unaffected by the addition of TNF-a to the cells for 24 h.
To measure noninvasively whether cell surface bound proteo-
lytic activity was modified by TNF-a, we also added BODIPYs
casein directly to the HBL melanoma cell culture medium during
the period of cell invasion through the fibronectin monolayer in
the invasion assay. Cell conditioned medium from the upper
chamber (noninvading cells) and the lower chamber (invading
cells) was sampled at the end of the 20-h assay period and the
fluorescence of the sample, representing protease activity, was
measured. TNF-a did not increase general protease activity in the
conditioned media in these experiments (results not shown).
Effect of a2 macroglobulin on HBL cell invasion
Although we had failed to show any effect of TNF-a on
proteolytic activity of HBL melanoma cells, it was still
conceivable that levels may have been beneath the level of
detection of these biochemical assays and that proteases played
some role in the invasion of these cells through fibronectin.
97.4 kDa 
66.3 kDa 
MMP-9 Control TNF- Control TNF- 
 
Cell extracts Conditioned medium
MMP-2
Figure 2 Representative gelatin zymograph of control and TNF-a-
stimulated HBL melanoma cell extracts and cell conditioned medium. Cells
constitutively expressed pro-MMP-2 (66.3 kDa band) in the culture
medium and no upregulation or activation of the latent enzyme was
observed after preincubation with TNF-a at 200 U ml1. Lanes 1 and 2
represent internal human purified MMP-2 and MMP-9 standards.
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Figure 3 (A) The proteolytic activity of a series of trypsin concentra-
tions was assessed by the quenched fluorescent substrate assay. Results
shown are of one representative experiment. Duplicate wells were used
for each trypsin concentration. (B) Inhibition of the proteolytic activity of
trypsin (3.3mg ml1) by the addition of the general protease inhibitor a2
macroglobulin. Inhibition of 84% was observed with a2 macroglobulin at a
concentration of 2 U ml1. Results show means7s.e.m. (n¼ 2, *Po0.05).
Table 1 Effect of TNF-a on the general protease activity of HBL cells
Net fluorescence units
TNF-a concentration
(U ml1)
Cell
extracts
Cell conditioned
medium
0 56997228 37767118
100 60577146 27267759
250 48577270 29087771
500 60667288 39297532
1000 51147744 24587437
Cells cultured in a 24-well plate were stimulated with the relevant TNF-a
concentration for 24 h prior to cell extraction and collection of cell conditioned
medium for measurement of protease activity using the quenched fluorescent
substrate assay. Results are the mean7s.e.m. of two separate experiments.
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Accordingly, we used a2 macroglobulin, an inhibitor of all classes
of endoproteases, to examine its effect on control and TNF-a
stimulated HBL melanoma cells. a2 macroglobulin inhibits
proteases present in the cell conditioned medium or on the cell
surface, but it cannot enter the cell or penetrate rapidly into the
extracellular matrix due to its large size (720 kDa tetrameric
glycoprotein).
Using the model of fibronectin invasion, a2 macroglobulin
(2 U ml1) was added to the cell suspension in the upper chamber
with or without TNF-a 200 U ml1 for the 20-h culture period of
the assay. Controls included cells with no stimulants and cells
where only TNF-a was added during the invasion assay. In three
separate experiments, a2 macroglobulin had no significant effect
on cell invasion through fibronectin (6% of the control level of
invasion), as summarised in Figure 4A. However, the significant
increase (Po0.05) in invasion observed following stimulation with
TNF-a (þ 21% of the control) was completely inhibited by the
addition of a2 macroglobulin.
Effect of a2 macroglobulin on HBL cell migration
a2 macroglobulin (2 U ml
1) was added to cells alone or in
combination with TNF-a (200 U ml1) for the 24-h duration of the
migration assay. The migration rate of the non-TNF-a stimulated
cells decreased by 26% (n¼ 3, Po0.05) when a2 macroglobulin
was added (see Figure 4B). The increase in cell migration seen on
TNF-a stimulation (þ 32% above the control, Po0.05) was
completely inhibited by the addition of the protease inhibitor
(again as shown in Figure 4B).
DISCUSSION
Inflammation represents the series of host responses triggered by
infectious agents and traumatic (mechanical, thermal, chemical or
radiation) insults. As such, it is invariably associated with the early
phases of wound healing and persists to a certain degree, until
regeneration of the injured tissues and restoration of function have
been achieved. (Robins and Kumar, 1987).
Surgical excision of cutaneous malignant melanoma is un-
doubtedly a very strong stimulus of inflammatory responses within
the skin as the wound healing process gets underway in the
immediate postoperative period. Locoregional and distant mela-
noma recurrences can occur despite wide margin and complete
tumour excision and well-conducted clinical studies have shown
that there were no statistically significant differences in disease-
free and overall survival rates when wide vs narrow margin
excisions were compared (Lens et al, 2002). This phenomenon of
locally recurrent tumours has led to speculations that some aspect
of the excision itself has led to a ‘seeding’ of the wound bed with
tumour cells that may have been present in the circulation but
were apparently ineffective in establishing metastases until a
wound was created.
To investigate this, animal studies have been undertaken which
suggested that mediators released locally in the wound and
systemically during the inflammatory phases of wound healing
promote the growth, invasion and metastatic potential of human
melanoma and other malignant tumour xenografts (Bogden et al,
1997; Hofer et al, 1998). There is also evidence from our laboratory
that melanoma invasion in a model of human reconstructed skin
requires the presence of host skin cells (namely fibroblasts and
keratinocytes) that express characteristics of ‘wounded’ skin (Eves
et al, 2000; Eves et al, in press). We recently reported that TNF-a
upregulated integrin expression in a human melanoma cell line
and also increased the ability of cells to bind to substrates and to
invade through fibronectin (Zhu et al, 2002).
The current study continues this work asking the question of
whether TNF-a promotes melanoma invasion through fibronectin
via activation of melanoma proteolytic enzymes. In brief, there are
two theories to explain how melanoma cells invade through ECM
proteins. One requires that there is increased migration of
melanoma cells along ECM proteins (Marshall et al, 1998), the
other that melanoma cells degrade the matrix proteins to migrate
through them (Bodey et al, 2001). In practice, it is almost certainly
the case that both will occur in vivo.
In this study, we focused on the question of whether TNF-a was
promoting melanoma invasion through fibronectin via upregula-
tion of proteolytic enzymes. The first step in this investigation was
to find the concentrations of TNF-a and the time course that was
optimal for TNF-a upregulation of cell invasion through fibro-
nectin and stimulation of migration. In practice, we found that
TNF-a at a concentration of around 100– 250 U ml1 added for
20–24 h produced maximal effects on both cell migration and cell
invasion. This result is consistent with previous reports from
Professor Ghanem’s laboratory that stimulation of HBL cells with
TNF-a for 24 h resulted in a maximal increase in the expression of
ICAM-1 (Morandini et al, 1998). Furthermore, previous work from
our group on the effects of TNF-a on two human cutaneous
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Figure 4 (A) Effect of the general protease inhibitor a2 macroglobulin at
a concentration of 2 U ml1 on HBL melanoma cell invasion through
fibronectin. When added to non-TNF-a-stimulated cells, the invasion was
not significantly reduced. In contrast, the increased invasion of the TNF-a-
stimulated cells was completely inhibited by a2 macroglobulin and the
invasion of these cells reduced to 8% of the control cell invasion. Results
are the mean7s.e.m. of three experiments, *Po0.05. (B) Effect of a2
macroglobulin (2 U ml1) on the migration of control and TNF-a-
stimulated cells. a2 macroglobulin decreased the control level of migration
and the increase in migration resulting from cell exposure to TNF-a was
completely inhibited by the protease inhibitor (n¼ 3, *Po0.05).
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melanoma cell lines, freshly isolated human ocular melanoma cells
and melanocytes, has shown potent activation of transcription
factor NFkB within 30 min of TNF-a stimulation (at a concentra-
tion of 200 U ml1) and significant inhibition by a-MSH in all the
cell types examined (Haycock et al, 1999). More recently, we have
demonstrated upregulation of integrin expression (specifically a3,
a4 and b1 integrin subunits) within 24 h of TNF-a exposure for the
HBL melanoma cells (Zhu et al, 2002) associated with TNF-a
stimulated increased invasion through fibronectin – an effect
largely blocked by a-MSH. Similar stimulatory effects of TNF-a
were also seen on the invasion of three different ocular melanoma
cell lines through fibronectin and MSH peptides blocked the
response to TNF-a (Canton et al, in press).
Integrins are important cell surface signalling molecules
expressed by normal and tumour cells and modulate processes
such as attachment, motility and degradative enzyme (MMP)
expression by the malignant cells (Jones and Walker, 1999).
Upregulation of their expression has been associated with
increased malignancy of melanoma cells (Marshall et al, 1998).
TNF-a induced upregulation of integrin expression could be a
critical step in the invasion of these cells.
Proteolytic enzymes have also been implicated in the process of
melanoma cell invasion (Hofmann et al, 2000; Bodey et al, 2001).
To investigate whether degradative enzyme upregulation is
involved in the increased cell invasion observed with TNF-a
stimulation, we examined the expression and activation of MMPs
-2 and -9 using gelatin zymography, and the general protease
activity of the melanoma cells using a quenched fluorescent
substrate assay. As maximal upregulation of cell invasion was
achieved with TNF-a between 100 and 250 U ml1 and previous
data from our group demonstrated maximal activation of NFkB in
these cells with 200 U ml1 of TNF-a (Haycock et al, 1999), we
decided to use TNF-a at a concentration of 200 U ml1 for
subsequent assays.
We were unable to demonstrate any increase to the expression
of pro-MMP-2 constitutively expressed by these cells or any
activation of the latent enzyme. Similarly, the general proteolytic
activity expressed in the cell conditioned medium and by the
melanoma cells themselves was not upregulated in response to
preincubation with a wide range of concentrations of TNF-a.
However, although this result seems very straightforward, it is
feasible that the levels of enzyme activity necessary for cell
migration or cell invasion through fibronectin were already
adequate for this purpose and that any increase in activity seen
in response to TNF-a might just simply have been too small to be
detected using these biochemical assays. It is possible that TNF-a
may induce a localised pericellular, or cell membrane-associated,
degradative enzyme activity sufficient for increased migration and
invasion. This activity may not have been detected using the casein
substrate.
For these reasons, we included the general protease inhibitor a2
macroglobulin. The large size of this protein precludes its access to
intracellular proteases and its activity is restricted to the outer cell
surface and extracellular space. With respect to invasion, a2
macroglobulin did not significantly reduce the basal level of
invasion, but did inhibit the TNF-a stimulated increase in cell
invasion. With respect to migration, a2 macroglobulin reduced
both the basal and the TNF-a stimulated level of migration. This
would be consistent with cellular migration involving some
proteolytic activity, although it was evident that the extent of the
inhibition was never more than about 26%. Thus, it is possible to
hypothesise that membrane-bound or immediately pericellular
proteolytic activity may be upregulated by TNF-a, allowing cells to
migrate more effectively on ECM substrates or even matrix laid
down by the cells themselves.
Other investigators have also recently reported upregulation of
proteolytic enzymes by TNF-a in murine bone marrow cells and
have also demonstrated increased in vitro degradation of bone
collagen following TNF-a stimulation of osteoclasts that was
successfully inhibited by the addition of a specific protease
inhibitor (Katunuma et al, 2002).
It must be noted, however, that TNF-a can elicit a wide variety of
biological responses in both normal and tumour cells (Balkwill,
2002). Some of these effects seem to be concentration dependent as
high tissue concentrations can induce both cell necrosis and
apoptosis (Balkwill, 2002). This effect is mediated via cell surface
death receptors and it has been recently reported that stabilisation
of these receptors in melanoma cells by cell exposure to the tissue
inhibitor of metalloproteinases-3 (TIMP-3) sensitised these cells to
apoptosis induced by TNF-a and other ligands (Ahonen et al,
2003).
The literature also reports that TNF-a may have complex effects
on the regulation of degradative enzymes. Johnson and Baglioni
(1990) have reported that stimulation with TNF-a induced
expression of plasminogen activator inhibitor, type 2 (PAI-2) in
SK-MEL-109 melanoma cells. This suggests that TNF-a may be a
potent regulator of degradative enzyme activity during malignant
cell invasion. More importantly, this study demonstrates that the
TNF-a cell response can be modulated (both upregulated and
downregulated) at a postreceptor level via activation of different
second-messenger systems suggesting that the effect of TNF-a on
various target cells can be modified inside the cell to produce the
cell’s final response to the cytokine.
Although our current study reports observations made on a
single cell line, our data are in agreement with previous reports
from the literature on the effects of TNF-a on the functional
biology of different human malignancies including melanoma
(Dekker et al, 1994; Balkwill, 2002) and extend ongoing work from
our group on the effects of proinflammatory cytokines on human
melanoma by examining the role of proteolytic enzymes in the
invasion and migration of these cells.
In conclusion, we report that the proinflammatory
cytokine TNF-a upregulates malignant melanoma invasion
and migration in vitro. Taken together, the results of our
current study combined with the data we have previously
published (Zhu et al, 2002) suggest that TNF-a may exert its
proinvasive effect on HBL melanoma cells via an integrin-
dependent mechanism as well as a modest upregulation of
degradative enzyme activity not readily detected in general
protease assays.
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